Related Experiment Video
Updated: Mar 2, 2026

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
Transcatheter closure of a membranous ventricular septal defect in a 1.8-kg infant using Amplatzer Duct Occluder II
Bhavik Champaneri1, Mahesh Kappanayil1, Raman K Kumar1
1Department of Pediatric Cardiology,Amrita Institute of Medical Sciences,Kochi,Kerala,India.
Insights
Catheter closure of membranous ventricular septal defects is challenging in infants. A novel device successfully closed a defect in a small infant, offering a new treatment option.
Area of Science:
- Pediatric Cardiology
- Interventional Cardiology
- Congenital Heart Disease
Background:
- Membranous ventricular septal defects (mVSDs) are common congenital heart defects.
- Catheter-based closure of mVSDs in small infants is technically challenging and often not considered feasible.
- Previous attempts at percutaneous closure in this population have had limited success.
Abstract:
Catheter closure of membranous ventricular septal defects is generally not considered feasible in small infants. We report the successful closure of a membranous ventricular septal defect in a 1.8-kg infant with bilateral femoral artery occlusion using Amplatzer Duct Occluder II additional size device. The ventricular septal defect was crossed from the right ventricle, and the device was deployed using transthoracic echocardiographic guidance.
More Related Videos
07:41Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
08:00Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter
Published on: June 15, 2015